RFPs for two components of an MDD clinical operations contract (clinical trials and regulatory affairs support) have been issued. Responses were due by May 10.
The NIDA Medications Development Database now has over 100 subscribers, including some universities and pharmaceutical companies in Western Europe. The database represents a resource for researchers working in the area of drug abuse and neuroscience. It is a tool which allows researchers to study relationships between structure and activity in the search for new and improved compounds to be targeted as treatment medications. The database now contains nearly 6,000 compounds and biological data consisting of receptor binding data and drug discrimination and self-administration studies, as well as toxicology. All data is preclinical. The database is available on a dial-up basis through an "800" number at no cost to the user. Individual training is also available at no cost to the user.
A Program Announcement # PA-95-022 "Drug Abuse Services Research and HIV/AIDS" was issued in January 1995. The purpose of this PA is to support a program of research on health services to drug abusers at high risk for HIV/AIDS at the client, program, and services system level.
On February 3, 1995, NIDA released a Program Announcement (PA-95-026) soliciting proposals for "HIV Disease Progression in Drug Users" to stimulate research on the biological and behavioral factors influencing HIV disease progression in populations of drug users in and out of drug abuse treatment in order to facilitate prevention and treatment efforts.
A Program Announcement entitled "Studies on the Linkage of Drug Abuse Treatment and Medical Care" was published in the NIH Guide on February 3, 1995. The purpose of this announcement is to stimulate research on various models and strategies for linking drug abuse treatment with medical care, with special attention to effects on the prevention, incidence and progression of medical (including psychiatric) disorders in drug abusing populations and the cost and effectiveness of linked treatment. "Linkage", in the context of this research program is defined as including at least the following components: (1) drug abuse treatment and (2) medical care, including at least (a) primary and/or acute care, (b) care related to mental disorders, and (c) public health aspects of medical care, e.g., screening for sexually transmitted diseases, immunizations.
A new Program Announcement, "Neuroscience Research of Nicotine and Nicotine Abuse" (PA 95-038) was published March 22, 1995. The announcement emphasizes studies on the addictive properties of nicotine.
A Request For Applications (RFA) # DA-95-005 "Health Services Research Centers" was issued on May 9, 1995 to support a program of Health Services Research Centers to conduct interdisciplinary research on financing, organization, access, and utilization of health services for drug abusers.
NIDA has joined the National Institute of Mental Health (NIMH), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and the National Institute on Aging (NIA) in issuing a Request for Applications (RFA) entitled "Family Interventions and HIV/AIDS." The term "family" here refers to the breadth of family configurations, including biological kin networks and nonrelated persons who consider themselves to be family through a "network of mutual commitment."
The purpose of the RFA, issued on April 14, 1995, is to encourage research on family interventions intended to enhance the ability of families to prevent the spread of HIV/AIDS and/or its consequences. Drug abuse is a key element of the RFA. Applications are due in June and funding of projects is expected by September.
NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version
|
NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version
|